Updated Aug 20, 2026
/Alibaba AI revenue tops 16 billion yuan in annual recurring sales/CCIF declares $0.06 monthly cash dividend, payable November 30/FDA grants Ultragenyx accelerated approval for GENGLYCOS in glycogen storage disease type Ia/Systematic funds post worst day since 2023 on momentum-driven selloff/Tim Walz blocks Minnesota mining permits near Boundary Waters, defying Trump energy law/UK Home Office nine-page guide tells asylum seekers rape is a crime and women need no male permission/Alibaba AI revenue tops 16 billion yuan in annual recurring sales/CCIF declares $0.06 monthly cash dividend, payable November 30/FDA grants Ultragenyx accelerated approval for GENGLYCOS in glycogen storage disease type Ia/Systematic funds post worst day since 2023 on momentum-driven selloff/Tim Walz blocks Minnesota mining permits near Boundary Waters, defying Trump energy law/UK Home Office nine-page guide tells asylum seekers rape is a crime and women need no male permission

Ademi LLP Investigates Crinetics Pharmaceuticals Over Vertex Transaction, Citing Fair-Price Concerns

Milwaukee law firm Ademi LLP has opened an investigation into Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) over the company's recently announced transaction with Vertex, examining whether Crinetics' board secured a fair price for public…

By Elias Vance2 min readGOOGL
Share